A comprehensive serum metabolomics study has revealed that bullous pemphigoid is associated with broad systemic metabolic reprogramming spanning energy metabolism, redox homeostasis, amino acid metabolism, and lipid signaling. Bullous pemphigoid is an autoimmune subepidermal blistering disease characterized by autoantibody-mediated inflammation, yet its broader systemic metabolic alterations have remained incompletely understood in clinical dermatology. To investigate these metabolic changes, a research team led by Jing Ni, Ying Zhu, Wei Bian, Hui Xiao, Ying Luo, Xiao-yao Song, and Zhi-qi Song conducted an untargeted metabolomic analysis comparing individuals with bullous pemphigoid to healthy control subjects. The peer-reviewed findings were published in Archives of Dermatological Research as part of volume 318.
To capture circulating molecular profiles across participants, the investigators performed metabolomic profiling of serum samples utilizing ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry. This high-resolution analytical workflow successfully detected a total of 4,288 metabolites across the patient and healthy control cohorts. When the team applied partial least squares-discriminant analysis to model the multidimensional metabolomic data, the score plots revealed a clear separation between the bullous pemphigoid cohort and the healthy controls. Further statistical evaluation showed that 452 of the 4,288 detected metabolites exhibited significant differential abundance between the two groups, confirming substantial divergence in circulating small-molecule concentrations between individuals affected by the autoimmune blistering disorder and healthy participants.
Classification of the 452 significantly altered metabolites showed that they were primarily distributed across four fundamental biochemical classes: carbohydrates, lipids, amino acids, and nucleotides. To understand how these altered molecules interact within biological systems, the researchers conducted pathway enrichment analysis. This computational evaluation identified coordinated perturbations across several major routes of central energy metabolism. Specifically, the analysis highlighted significant disruptions in glycolysis and gluconeogenesis, the pentose phosphate pathway, and the tricarboxylic acid cycle. Beyond primary carbohydrate and energy metabolism, pathway enrichment analysis revealed coordinated alterations in sulfur-containing amino acid metabolism, glutathione-related pathways involved in redox homeostasis, and broader enzymatic pathways governing systemic lipid remodeling.
To elucidate specific molecular interactions, the study incorporated network-level analysis, which demonstrated distinct directional patterns among the perturbed metabolic pathways. In the central energy pathways, network evaluation showed a decreased abundance of multiple metabolic intermediates within both glycolysis and the tricarboxylic acid cycle in patients with bullous pemphigoid. Concurrently, network-level analysis revealed broad structural remodeling across circulating lipid classes. These alterations prominently affected lysophospholipids, membrane phospholipids, and signaling networks associated with sphingolipids. Together, these coordinated findings demonstrate that systemic metabolic reprogramming in bullous pemphigoid involves widespread suppression of key energy intermediates alongside extensive modifications to cellular membrane architecture and bioactive lipid signaling cascades.
The researchers noted important limitations inherent to the study design, emphasizing that the work was conducted as an exploratory investigation and was constrained by the limited availability of detailed clinical covariates. Because of these factors, the authors cautioned that the observed associations between altered serum metabolites and bullous pemphigoid must be interpreted as hypothesis-generating rather than demonstrating causal mechanisms. Nonetheless, the investigation delivers a systematic serum metabolomic overview of the autoimmune condition and maps critical points of systemic metabolic disruption. By delineating specific perturbations in central energy pathways, redox homeostasis, and lipid signaling, the study establishes an evidence-based set of candidate metabolic pathways to direct future mechanistic investigations and prospective biomarker-validation studies.
Subject of Research: Serum metabolomic alterations in bullous pemphigoid
Article Title: Serum metabolomics reveals systemic metabolic reprogramming associated with bullous pemphigoid
Article References: Ni, J., Zhu, Y., Bian, W., Xiao, H., Luo, Y., Song, X.-Y., & Song, Z.-Q. (2026). Serum metabolomics reveals systemic metabolic reprogramming associated with bullous pemphigoid. Archives of Dermatological Research, 318(1), Article 566. https://doi.org/10.1007/s00403-026-05006-7
Image Credits: AI Generated
DOI: 10.1007/s00403-026-05006-7
Keywords: bullous pemphigoid, serum metabolomics, metabolic reprogramming, high-resolution mass spectrometry, liquid chromatography, glycolysis, tricarboxylic acid cycle, pentose phosphate pathway, lipid remodeling, lysophospholipids, membrane phospholipids, sphingolipid signaling, sulfur-containing amino acids, glutathione metabolism, redox homeostasis, partial least squares discriminant analysis, energy metabolism, autoimmune blistering disease
News Source: Ophelia Keating. (November 14, 2026). Bullous Pemphigoid Is Associated With Broad Serum Metabolic Reprogramming. Scienmag.



